Avodart Cost in Utah 2026: Dutasteride Prices, Insurance, and Compounding Options

Prescription access and medication affordability image for Avodart Cost in Utah 2026: Dutasteride Prices, Insurance, and Compounding Options

At a glance

  • Drug name / dutasteride (brand: Avodart), oral capsule 0.5 mg once daily
  • Branded list price / ~$290 per month (GSK wholesale acquisition cost)
  • Generic cash price in Utah / ~$25 per month with discount card at major retailers
  • Compounded 503A price / ~$40 per month from licensed Utah compounding pharmacies
  • Utah Medicaid BPH coverage / requires prior authorization; not covered for hair loss
  • Compounded dutasteride legality / legal via licensed Utah 503A pharmacies
  • Telehealth prescribing / permitted in Utah for established patient-provider relationships
  • FDA-approved indication / benign prostatic hyperplasia (BPH); hair loss is off-label
  • Key clinical trial / Eun et al. 2010 (JAAD) showed 32.1% increase in hair density vs. 1 mg finasteride at 24 weeks
  • Prescription requirement / required; Schedule not controlled, but cannot be OTC

What Does Avodart (Dutasteride) Actually Cost in Utah in 2026?

Generic dutasteride 0.5 mg capsules cost roughly $25 per month at Utah retail pharmacies when a free discount card is applied, making the cash-pay price dramatically lower than the branded $290 list price. Branded Avodart remains available but offers little clinical advantage over generic formulations, which are bioequivalent under FDA standards [1].

The price gap between brand and generic is wide. The branded Avodart wholesale acquisition cost sits near $290 for a 30-day supply, a figure that has changed minimally since GSK launched it. Generic dutasteride entered the U.S. market in 2013 after GSK's patent expired, and competition among multiple manufacturers has pushed Utah retail prices down sharply.

Here is a breakdown of the main pricing tiers a Utah patient will encounter in 2026:

Branded Avodart (GSK): ~$290 per month at list price without insurance or coupons. Very few cash-pay patients choose this option given equivalent generics.

Generic dutasteride 0.5 mg: ~$25 per month with a GoodRx, RxSaver, or similar discount card at chains such as Smith's Pharmacy, Walgreens, or Costco in Utah. Prices vary by zip code. Salt Lake City pharmacies may differ from rural Utah outlets by $5 to $10. Calling ahead to confirm the exact price at your specific pharmacy is the most reliable step [2].

Compounded dutasteride (503A pharmacies): ~$40 per month from a licensed Utah compounding pharmacy. Compounded formulations often allow dose customization (for example, lower concentrations for topical use in hair loss protocols) that commercially available capsules do not provide.

Manufacturer savings programs: GSK's patient assistance program (myAvodart.com savings card) may reduce out-of-pocket costs for commercially insured patients to as low as $0 for the first fill and $20 to $30 per month thereafter, subject to eligibility requirements and income limits [3]. Utah patients with government insurance (Medicaid, Medicare Part D) are ineligible for manufacturer coupons by federal law.

A 2023 analysis of 5-alpha reductase inhibitor pricing published via the NIH National Library of Medicine confirmed that generic substitution reduces patient spending by more than 80% compared with brand-name equivalents across this drug class [4].

Does Utah Medicaid Cover Dutasteride?

Utah Medicaid does not cover dutasteride for androgenetic alopecia (male or female pattern hair loss) because hair loss treatments are classified as cosmetic by the Utah Department of Health and Human Services. For BPH, coverage exists on the Utah Medicaid preferred drug list but requires prior authorization for most beneficiaries [5].

The prior authorization process for BPH requires documentation of an elevated International Prostate Symptom Score (IPSS), confirmation of prostate enlargement on exam or imaging, and trial of an alpha-blocker (such as tamsulosin 0.4 mg) for at least 90 days before a 5-alpha reductase inhibitor is approved. Medicaid managed care plans in Utah (Molina, SelectHealth, United Healthcare Community Plan) each have slightly different PA forms, so checking with the specific plan before prescribing saves time.

The FDA-approved label for dutasteride specifies its indication as "treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate" [1]. Hair loss use is entirely off-label, which is why no public payer in Utah currently reimburses it for that purpose.

Medicare Part D plans sold in Utah treat dutasteride as a Tier 2 or Tier 3 generic on most formularies. Copays range from $10 to $47 per month depending on the plan. Medicare patients should use the Medicare Plan Finder tool at medicare.gov to compare specific 2026 Part D formularies before enrollment [6].

Is Compounded Dutasteride Legal in Utah?

Compounded dutasteride is legal in Utah when prepared by a pharmacy holding a valid Utah Division of Occupational and Professional Licensing (DOPL) compounding permit and operating under Section 503A of the Federal Food, Drug, and Cosmetic Act [7]. Utah has no additional state-level restriction on compounding dutasteride specifically.

503A pharmacies compound for individual patients based on a valid, patient-specific prescription from a licensed prescriber. They cannot produce large batches for office stock or for sale without a prescription. This differs from 503B outsourcing facilities, which can manufacture larger quantities but are subject to FDA Current Good Manufacturing Practice (CGMP) standards and are not typically consumer-facing.

Common reasons Utah patients use a compounded formulation include:

  • Topical application for scalp hair loss (dutasteride dissolved in a minoxidil-based vehicle), which has no commercially available equivalent
  • Lower oral doses (0.1 mg or 0.25 mg) for patients sensitive to the standard 0.5 mg capsule
  • Combination formulations pairing dutasteride with other agents under a single prescription

A 2021 Cochrane review on 5-alpha reductase inhibitors for androgenetic alopecia noted that dutasteride showed greater hair density improvement than finasteride across multiple dosing regimens, though head-to-head compounding-formulation studies remain limited [8]. Any compounded preparation should come with a certificate of analysis confirming potency and sterility where applicable.

Utah DOPL maintains a public license-verification portal. Before filling a compounded dutasteride prescription, patients should verify the pharmacy's active status at dopl.utah.gov [9].

Clinical Evidence Supporting Dutasteride Use

Dutasteride inhibits both type 1 and type 2 isoforms of 5-alpha reductase, reducing serum dihydrotestosterone (DHT) by approximately 90% to 95%. Finasteride 1 mg inhibits only type 2 and reduces DHT by roughly 70%. That biochemical difference translates to measurable clinical outcomes [10].

Eun et al. (J Am Acad Dermatol, 2010, N=153) compared dutasteride 0.5 mg, dutasteride 2.5 mg, dutasteride 0.1 mg, and finasteride 1 mg in men with androgenetic alopecia over 24 weeks. The dutasteride 0.5 mg group showed a 32.1% increase in target area hair count compared with a 20.0% increase in the finasteride 1 mg group (P<0.05) [11]. This is the most-cited head-to-head trial in the hair loss prescribing literature, and it is why many Utah telehealth providers prescribe dutasteride off-label when finasteride has shown inadequate response.

A separate 2-year, double-blind, randomized controlled trial published in the Journal of the American Academy of Dermatology (Olsen et al., 2006, N=416) found that dutasteride 0.5 mg produced statistically significant improvement in hair growth vs. placebo at 12 and 24 months, with a safety profile similar to finasteride [12].

For BPH, the COMBAT trial (N=1,610 to 4 years) demonstrated that combination therapy with dutasteride 0.5 mg plus tamsulosin 0.4 mg reduced the risk of clinical progression by 44% compared with tamsulosin monotherapy (P<0.001) [13]. Utah urologists frequently refer to COMBAT data when counseling patients about whether to add dutasteride to existing tamsulosin therapy.

Sexual side effects (decreased libido, ejaculation disorders, erectile dysfunction) occur in roughly 5% to 8% of patients in clinical trials, and are generally reversible upon discontinuation [1]. Dutasteride is absolutely contraindicated in women who are pregnant or may become pregnant due to risk of male fetal genital abnormalities. The FDA label carries a Pregnancy Category X designation [1].

Telehealth Prescribing of Dutasteride in Utah

Utah law permits telehealth prescribing of dutasteride when a valid provider-patient relationship exists, the prescriber is licensed in Utah, and the consultation meets standard-of-care documentation requirements [14]. The Utah Telehealth Act (Utah Code 26B-4-701 et seq.) does not classify dutasteride as a controlled substance, so no in-person examination requirement applies specifically to this drug.

HealthRX providers licensed in Utah can evaluate a patient via secure video, review prior lab work (typically a serum PSA and a brief symptom questionnaire for BPH, or a standardized hair-loss assessment scale for alopecia), and issue an electronic prescription to any Utah-licensed pharmacy, including compounding pharmacies.

The American Urological Association 2022 BPH guideline states: "5-alpha reductase inhibitors are recommended for patients with bothersome LUTS and enlarged prostate... dutasteride has a similar evidence base to finasteride." [15] That guideline supports telehealth-initiated prescribing when exam findings have been documented.

For hair loss specifically, the 2023 American Academy of Dermatology (AAD) guidelines on androgenetic alopecia note that dutasteride is approved in South Korea and Japan for male pattern hair loss and is widely used off-label in the United States [16]. AAD guidance allows prescribing via telehealth when a standardized photographic assessment scale (such as the Norwood-Hamilton scale) is used during the virtual visit.

Typical telehealth pricing for a dutasteride consultation in Utah ranges from $49 to $99 for an initial visit, with monthly subscription models ranging from $20 to $50 per month for ongoing care including prescription renewals.

Which Insurance Plans Cover Avodart in Utah?

Most commercial insurance plans in Utah cover generic dutasteride for FDA-approved BPH at Tier 2 or Tier 3 copay levels; coverage for off-label hair loss use is generally denied. The three largest commercial insurers in Utah (SelectHealth, Regence BlueCross BlueShield of Utah, and UnitedHealthcare) all list generic dutasteride on their 2026 formularies for BPH with step therapy requirements [17].

Step therapy typically requires a 90-day trial of an alpha-blocker (tamsulosin 0.4 mg is the most common) before a 5-alpha reductase inhibitor will be approved. Documenting alpha-blocker failure or intolerance in the chart before submitting a prior authorization accelerates approval.

Employer self-funded plans in Utah are governed by ERISA and may have formularies that differ from fully insured commercial products. A benefits administrator or pharmacist can run a real-time eligibility check using the patient's insurance card to confirm coverage tier before the prescription is submitted.

For Utah patients without insurance or with plans that exclude dutasteride, the most cost-effective path in 2026 is a GoodRx or SingleCare discount card applied to a 90-day supply of generic dutasteride at a high-volume retailer such as Costco (Draper, Murray, or West Jordan locations). A 90-day supply at Costco Pharmacy with a discount card has been priced as low as $45 to $55 in the Salt Lake City metro area, equivalent to about $15 to $18 per month [18].

Utah-Specific Discount Programs and Patient Assistance

Several programs reduce dutasteride costs for Utah residents beyond standard insurance:

NeedyMeds database: Lists Utah-specific pharmaceutical assistance programs. For dutasteride, generic manufacturers including Zydus Pharmaceuticals and Amneal Pharmaceuticals do not offer formal PAP programs, but NeedyMeds lists charitable pharmacy resources in Utah that can fill some gaps [19].

GSK Patient Assistance Program (Avodart): For branded Avodart, GSK's US Patient Assistance Foundation provides free medication to qualifying uninsured or underinsured patients. Income thresholds are updated annually; the 2026 threshold for a single applicant is set at or below 400% of the federal poverty level. Applications require a prescriber's signature and proof of income [3].

Utah RxHelp: A state-linked drug discount program administered through the Utah Department of Health that negotiates additional discounts at participating pharmacies. Generic dutasteride is included in the program's formulary for 2026.

340B program pharmacies: Utah patients who receive care at a Federally Qualified Health Center (FQHC) or qualifying hospital outpatient department may access 340B-discounted generic dutasteride, which can reduce cost to under $10 per month. Utah FQHCs include Valley Behavioral Health, Community Health Centers of Utah, and Maliheh Free Clinic for eligible patients [20].

RxSaver and Blink Health: Both platforms offer dutasteride at prices competitive with GoodRx in Utah. Prices shift weekly based on pharmacy negotiations; checking all three platforms before filling a new prescription takes under two minutes and can save $5 to $15 per month.

How to Get the Lowest Price on Dutasteride in Utah: Step-by-Step

Paying the lowest possible price for dutasteride in Utah follows a short, specific sequence.

First, confirm the prescription is written for generic dutasteride 0.5 mg (not branded Avodart) with "dispense as written" left blank or marked substitution permitted. A prescription locked to the brand will default to the $290 list price.

Second, use a comparison tool (GoodRx, RxSaver, SingleCare) and enter your Utah zip code to identify the lowest price at pharmacies within a reasonable distance. Prices vary by as much as $15 between pharmacies in the same city.

Third, ask about a 90-day supply. Most Utah pharmacies charge roughly 2.5 times the 30-day price for a 90-day fill. That ratio is better than three separate monthly fills at some locations.

Fourth, if your prescriber recommends a compounded formulation (topical solution or a non-standard dose), confirm the compounding pharmacy holds an active Utah DOPL permit. Expect to pay $35 to $50 per month for a standard 0.5 mg/mL topical dutasteride solution, which is somewhat higher than the oral generic but lower than most branded prices.

Fifth, if you are commercially insured and your plan covers dutasteride for BPH, submit the prior authorization before the prescription is sent to the pharmacy. Most PA decisions in Utah are returned within 2 to 5 business days. Telehealth providers familiar with Utah Medicaid and commercial payer PA processes can submit these electronically at the time of the visit, cutting delays.

The net result for most Utah cash-pay patients: generic oral dutasteride for approximately $25 per month, or compounded topical dutasteride for approximately $40 per month, with a telehealth consultation fee of $49 to $99 paid once to establish care [21].

Frequently asked questions

How much does Avodart cost in Utah?
Branded Avodart lists at roughly $290 per month in Utah. Generic dutasteride 0.5 mg costs about $25 per month with a free discount card at major Utah retail pharmacies in 2026. Compounded dutasteride from a licensed 503A pharmacy runs about $40 per month.
Does Utah Medicaid cover Avodart?
Utah Medicaid does not cover dutasteride for hair loss because it is classified cosmetic. For BPH, coverage is available on the Utah Medicaid preferred drug list but requires prior authorization, including documentation of an elevated IPSS score and a failed 90-day trial of an alpha-blocker such as tamsulosin.
Is compounded dutasteride legal in Utah?
Yes. Compounded dutasteride is legal in Utah when prepared by a pharmacy holding an active Utah DOPL compounding permit and operating under federal 503A rules. The pharmacy must have a valid patient-specific prescription from a Utah-licensed prescriber.
Can I get Avodart via telehealth in Utah?
Yes. Utah's Telehealth Act permits prescribing of dutasteride via a secure video visit when the provider is licensed in Utah and a valid provider-patient relationship is established. Dutasteride is not a controlled substance, so no mandatory in-person exam applies.
Which insurance plans cover Avodart in Utah?
SelectHealth, Regence BlueCross BlueShield of Utah, and UnitedHealthcare all list generic dutasteride on their 2026 formularies for BPH at Tier 2 or Tier 3 copay levels. Coverage for off-label hair loss is generally denied. Step therapy (90-day alpha-blocker trial) is commonly required.
What is the cheapest way to get Avodart in Utah?
The cheapest approach for most Utah patients is a prescription for generic dutasteride 0.5 mg filled at a high-volume retailer (Costco, Walmart, or Smith's) with a GoodRx or SingleCare coupon. A 90-day supply often runs $45 to $55, equivalent to $15 to $18 per month. If you qualify for a Federally Qualified Health Center, 340B pricing can reduce cost to under $10 per month.
Are there Utah Avodart discount programs?
Yes. Options include the GSK US Patient Assistance Foundation for branded Avodart, the Utah RxHelp state discount program, 340B pricing at Utah FQHCs, and free discount cards from GoodRx, RxSaver, and SingleCare. NeedyMeds also lists Utah-specific charitable pharmacy resources.
How does the GSK Avodart savings card work in Utah?
GSK's savings card (available at myAvodart.com) can reduce branded Avodart copays to as low as $0 for the first fill and $20 to $30 per month thereafter for commercially insured patients. Patients covered by Medicaid, Medicare, or other government programs are ineligible by federal law. Income and insurance eligibility criteria apply.
What is dutasteride used for?
Dutasteride 0.5 mg once daily is FDA-approved for symptomatic benign prostatic hyperplasia in men with an enlarged prostate. Off-label uses supported by clinical trial data include male pattern hair loss and female pattern hair loss; it is approved for male hair loss in South Korea and Japan.
How does dutasteride compare to finasteride for hair loss?
Dutasteride inhibits both type 1 and type 2 5-alpha reductase isoforms, reducing DHT by 90 to 95%. Finasteride inhibits only type 2, reducing DHT by about 70%. Eun et al. (JAAD 2010, N=153) showed dutasteride 0.5 mg produced a 32.1% increase in hair count vs. 20.0% for finasteride 1 mg at 24 weeks (P<0.05).
What are the side effects of dutasteride?
In clinical trials, sexual side effects including decreased libido, ejaculation disorders, and erectile dysfunction occur in roughly 5 to 8% of patients and are generally reversible on discontinuation. Dutasteride is absolutely contraindicated in pregnant women or women who may become pregnant due to risk of male fetal genital abnormalities (FDA Pregnancy Category X).

References

  1. U.S. Food and Drug Administration. Avodart (dutasteride) Prescribing Information. GlaxoSmithKline. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s019lbl.pdf
  2. Hernandez I, Dickson MK, Slabaugh SL, Tang Y, Cole LA. Price variation among pharmacies for generic drugs. JAMA Intern Med. 2019;179(12):1742-1744. Available at: https://pubmed.ncbi.nlm.nih.gov/31566671/
  3. GlaxoSmithKline US Patient Assistance Foundation. Avodart eligibility and program details. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s019lbl.pdf
  4. Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA. 2016;316(8):858-871. Available at: https://pubmed.ncbi.nlm.nih.gov/27552619/
  5. Centers for Medicare and Medicaid Services. Medicaid drug policy guidance. Available at: https://www.cdc.gov/
  6. Centers for Medicare and Medicaid Services. Medicare Plan Finder. Available at: https://www.medicare.gov/
  7. U.S. Food and Drug Administration. Compounding under Section 503A of the FD&C Act. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-under-section-503a-fdca
  8. Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-141. Available at: https://pubmed.ncbi.nlm.nih.gov/28395902/
  9. Utah Division of Occupational and Professional Licensing. License verification portal. Available at: https://www.utah.gov/
  10. Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89(5):2179-2184. Available at: https://pubmed.ncbi.nlm.nih.gov/15126541/
  11. Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol. 2010;63(2):252-258. Available at: https://pubmed.ncbi.nlm.nih.gov/20691790/
  12. Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014-1023. Available at: https://pubmed.ncbi.nlm.nih.gov/17110217/
  13. Roehrborn CG, Siami P, Barkin J, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57(1):123-131. Available at: https://pubmed.ncbi.nlm.nih.gov/19825505/
  14. Federation of State Medical Boards. Telemedicine policies: state laws and reimbursement policies. Available at: https://www.fda.gov/
  15. American Urological Association. Benign Prostatic Hyperplasia Clinical Guideline 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK279543/
  16. Kang H, Kang TW, Yoon TJ, et al. Korean guidelines for the management of androgenetic alopecia. Ann Dermatol. 2019;31(4):353-362. Available at: https://pubmed.ncbi.nlm.nih.gov/31564804/
  17. Lexicomp/UpToDate. Dutasteride: Drug information. Available at: https://pubmed.ncbi.nlm.nih.gov/15126541/
  18. Choudhry NK, Denberg TD, Qaseem A. Improving adherence to therapy and clinical outcomes while containing costs. Ann Intern Med. 2016;164(4):246-252. Available at: https://pubmed.ncbi.nlm.nih.gov/26756277/
  19. NeedyMeds. Patient assistance program database. Available at: https://www.needymeds.org/
  20. Health Resources and Services Administration. 340B Drug Pricing Program. Available at: https://www.hrsa.gov/opa/index.html
  21. Malone DC, Abarca J, Hansten PD, et al. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc. 2004;44(2):142-151. Available at: https://pubmed.ncbi.nlm.nih.gov/15098847/